Diagnostic Evaluation Of PSA Recurrence And Review Of Hormonal Management After Radical Prostatectomy

UroToday.com - At present, no consensus exists on how patients with PSA recurrence after radical prostatectomy (RP) should be treated. Although patients with postoperative PSA recurrence frequently undergo androgen deprivation therapy (ADT) before evidence of metastatic disease, the benefit of this approach is uncertain. As no randomized studies are performed in this clinical setting there is no conclusive evidence that hormone therapy (HT) after RP will prolong survival or reduce morbidity.

More: continued here

Filed under: Cancer on May 18th, 2009